{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=End-stage+Liver+Disease&page=2", "query": { "condition": "End-stage Liver Disease", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=End-stage+Liver+Disease&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T14:58:39.718Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01933789", "title": "Improving Communication About Serious Illness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Critical Illness", "Chronic Disease", "Terminal Care", "Palliative Care", "Communication", "Advance Care Planning", "Neoplasm Metastasis", "Lung Neoplasms", "Pulmonary Disease, Chronic Obstructive", "Heart Failure", "End Stage Liver Disease", "Kidney Failure, Chronic" ], "interventions": [ { "name": "Communication Feedback Form for Patients with Serious Illness", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 817, "start_date": "2013-09", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-03-20", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 6, "location_summary": "Renton, Washington • Seattle, Washington", "locations": [ { "city": "Renton", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01933789" }, { "nct_id": "NCT03580629", "title": "Pilot Study of the Liver Live Donor Champion Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Liver Disease" ], "interventions": [ { "name": "Liver Live Donor Champion Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 76, "start_date": "2018-09-18", "completion_date": "2025-11-29", "has_results": false, "last_update_posted_date": "2025-12-22", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03580629" }, { "nct_id": "NCT03266575", "title": "Pulmonary Rehabilitation in End-Stage Liver Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Liver Disease" ], "interventions": [ { "name": "Pulmonary Rehabilitation Exercise", "type": "BEHAVIORAL" }, { "name": "Home Based Exercise", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2018-02-01", "completion_date": "2024-12-09", "has_results": false, "last_update_posted_date": "2024-12-12", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03266575" }, { "nct_id": "NCT00682110", "title": "Hemodynamic Measurements During Liver Transplantation", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Liver Transplantation" ], "interventions": [], "intervention_types": [], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2007-07", "completion_date": "2010-03", "has_results": false, "last_update_posted_date": "2010-04-01", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00682110" }, { "nct_id": "NCT02864199", "title": "A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "Peginterferon alfa-2a", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 63, "start_date": "2004-02", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2016-08-11", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Kansas City, Kansas • New Orleans, Louisiana + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02864199" }, { "nct_id": "NCT00228592", "title": "HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis B", "Liver Transplantation" ], "interventions": [ { "name": "HepeX-B", "type": "DRUG" }, { "name": "Hepatitis B Immune Globulin (HBIg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": "2005-08", "has_results": false, "last_update_posted_date": "2007-02-13", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 12, "location_summary": "Los Angeles, California • San Francisco, California • Rochester, Minnesota + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00228592" }, { "nct_id": "NCT03934736", "title": "HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "End Stage Renal Disease on Hemodialysis (Diagnosis)" ], "interventions": [ { "name": "HEPLISAV-B®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dynavax Technologies Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2019-04-22", "completion_date": "2021-09-15", "has_results": true, "last_update_posted_date": "2024-08-09", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 20, "location_summary": "Bloomfield, Connecticut • Middlebury, Connecticut • Hollywood, Florida + 17 more", "locations": [ { "city": "Bloomfield", "state": "Connecticut" }, { "city": "Middlebury", "state": "Connecticut" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03934736" }, { "nct_id": "NCT04613921", "title": "Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Liver Diseases", "Liver Cirrhosis", "Acute-On-Chronic Liver Failure", "Liver Transplant; Complications" ], "interventions": [ { "name": "Observational Protocol", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "European Foundation for Study of Chronic Liver Failure", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 3000, "start_date": "2021-07-08", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 18, "location_summary": "Los Angeles, California • Aurora, Colorado • Tampa, Florida + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04613921" }, { "nct_id": "NCT06987968", "title": "A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatic Encephalopathy", "Acute on Chronic Liver Failure (ACLF)", "Decompensated Cirrhosis" ], "interventions": [ { "name": "VS-01 on top of SOC (Active Treatment Group)", "type": "DRUG" }, { "name": "SOC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genfit", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 3, "start_date": "2025-08-25", "completion_date": "2025-09-15", "has_results": false, "last_update_posted_date": "2026-01-12", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06987968" }, { "nct_id": "NCT04614142", "title": "Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "End Stage Renal Disease", "Chronic Hepatitis c" ], "interventions": [ { "name": "Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "34 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "34 Years to 44 Years · Female only" }, "enrollment_count": 0, "start_date": "2020-11-13", "completion_date": "2021-08-04", "has_results": false, "last_update_posted_date": "2022-03-08", "last_synced_at": "2026-06-10T14:58:39.718Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04614142" } ] }